Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

A Comprehensive Review of N-Heterocycles as Cytotoxic Agents

Author(s): Dinesh Kumar and Subheet Kumar Jain

Volume 23, Issue 38, 2016

Page: [4338 - 4394] Pages: 57

DOI: 10.2174/0929867323666160809093930

Price: $65

Abstract

Scientific community is striving to understand the role of heterocycles and fused heterocycles in drug discovery programme due to its impact on multi-drug resistance (MDR) of anticancer drugs. Architecting of various scaffolds for cancer treatment has become gradually increased in many years. Till now there is no treatment which is so proficient that it can cure the cancer from the roots. Hence, it is very necessary to design novel anticancer agents with minimum side effects. Synthesis of hybrids from natural leads is one of the rationale approaches in medicinal chemistry. It remains a big challenge to invent new efficient drugs to beat cancer. The design and synthesis of fused molecules as anticancer agents is one of the great innovations of modern era. In drug discovery archetype, a variety of heterocycles have been considered for the development of novel lead compounds. This article presents some recent advancements in the field of anticancer heterocyclic agents all around the world and also attracted the structure activity relationship along with the structure of the most promising molecules along with IC50 values against various human cancer cell lines.

Keywords: N-Heterocycles, Cytotoxic Agents, Fusion, Natural leads, IC50, Oxadiazoles.

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy